Market Research Blog – Page 1190 – New Product Development

Global Proteinase K Market Projected to Reach USD 43.9 Million by 2033, Growing at 4.8% CAGR

The Proteinase K market is on track for substantial growth, with an anticipated valuation of USD 27.5 million in 2023. Projections indicate that the market will experience a steady rise at a compound annual growth rate (CAGR) of 4.8% through 2033, potentially reaching an impressive valuation of USD 43.9 million.

This consistent growth trajectory is driven by the increasing demand for Proteinase K in various applications, including molecular biology, biotechnology, and pharmaceutical research. Its effectiveness in protein digestion and its critical role in nucleic acid extraction processes make it an essential enzyme for laboratories and research facilities worldwide.

A plethora of factors are expected to impact the growth of the Global Proteinase K Industry. A significant rise in research and development activities, lesser production costs, broader application of Proteinase K, and good product stability and specificity of Proteinase K will give a massive push to the revenue growth of the Global Proteinase K Industry by the end of the forecast period. A steady rise of chronic diseases and better government-backed investment channels to fund advanced research and development are expected to boost the expansion of the Global Proteinase K Industry throughout the assessment. An increasing number of research activities, soaring expenditure on personal healthcare, and increasing adoption of gene therapy have been significantly high in the U.S. market in recent years, making North America the most lucrative regional market for Proteinase K.

Global Proteinase K Industry: Segmental Forecast

By form, the lyophilized powder form segment is anticipated to account for a higher revenue share in the global Proteinase K as compared to the liquid form segment. Lyophilized powder from the segment is expected to reach a market value of US$ 19.2 Mn by 2026, reflecting a CAGR of 6.3% over the forecast period. The growth in lyophilized powder form can be attributed to the increasing advantages of powder form over liquid form in the case of storage and preservation of samples.
By application, purification of DNA & RNA segment will account for the highest revenue share in the Global Proteinase K Industry as compared to other applications of Proteinase K. Purification of DNA & RNA segment is expected to reach a value of US$ 19.2 Mn by 2026, reflecting a CAGR of 6.5% over the forecast period.
By end user, the biotechnology companies segment is expected to project higher demand for Proteinase K as compared to other end-user segments such as academic institutes and diagnostics laboratories. The strong growth in biotechnology companies can be attributed to an increasing use of Proteinase K in research and development and new drug discovery. The cost-effectiveness of Proteinase K over other reagents is the key factor responsible for its increasing use in biotechnology companies. The biotechnology companies segment is expected to register the highest CAGR of 6.7% over the forecast period.

Global Proteinase K Industry Regional Market Projections

Demand for research in academics and funding facilities provided by the U.S. government to support gene therapy and other activities for drug development is anticipated to boost the North American Proteinase K market. Followed by North America, Western Europe, and APEJ are the most lucrative regions in the global Proteinase K market and are anticipated to grow by 5.7% and 6.1% respectively over the forecast period. Increasing demand for drug development, rising hereditary diseases due to changing lifestyles, and growing disposable income are some of the factors expected to contribute to the growth of the Global Proteinase K Industry.

Global Proteinase K Industry: Vendor Insights

Top companies profiled in the Global Proteinase K Industry report include Thermo Fisher Scientific Inc., Merck KGaA, Qiagen N.V., Worthington Biochemical Corporation, Sisco Research Laboratories Pvt. Ltd, Promega Corporation, Bioline and F. Hoffmann-La Roche AG among others. Leading market players are adopting different strategies such as product launches and acquisitions to maintain their market share. For instance, in November 2015, Merck KGaA acquired Sigma-Aldrich to strengthen and expand its consumable and reagent portfolio.

Global Proteinase K Industry Segmentation Form

Lyophilized Powder Form
Liquid Form

Application

Isolation and purification of genomic DNA & RNA
In Situ Hybridization
Mitochondria isolation
Enzyme Removal

Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Pediatric Vaccine Market Set for Significant Growth, Projected to Reach USD 184,706.7 Million by 2033 at a 13.1% of CAGR

The global pediatric vaccine market is currently valued at USD 54,130.1 million in 2023 and is predicted to experience remarkable growth at a compound annual growth rate (CAGR) of 13.1%. By 2033, the market is expected to reach an impressive valuation of USD 184,706.7 million, highlighting its potential for significant expansion in the coming years.

This anticipated growth in the pediatric vaccine market is driven by several factors, including the rising awareness of the importance of vaccination for preventing infectious diseases, increased government initiatives to improve immunization rates, and ongoing research and development of new vaccines. The growing focus on public health and child safety further fuels the demand for effective vaccination programs globally.

This impressive growth reflects increasing global awareness of vaccination’s importance in preventing childhood diseases and advancements in vaccine development. The rise in vaccine coverage and the introduction of new and improved pediatric vaccines are driving the market’s expansion.

The paediatric vaccine market is a billion-dollar market accounting for a substantial proportion of healthcare expenditure in recent times. The paediatric vaccine market is segmented according to indication, technology and vaccine type. According to the indication, the paediatric vaccine market is sub-segmented into pneumococcal, DTP, rotavirus, influenza, meningococcal, hepatitis B, Hib, MMR and polio. According to technology, the market is further segmented into live or attenuated, inactivated or killed, toxoid, conjugate, subunit and recombinant vaccines. By vaccine type, the global paediatric vaccine market is segmented into monovalent and multivalent vaccines.

A slew of routine immunisation initiatives rolled out by the government and private agencies have broadened the market for paediatric vaccines. A new wave of funds pumped into the market by different government and private players to curb the rise of child deaths across the globe has also opened a new window of opportunity for the paediatric vaccine market. As per the report of WHO (World Health Organization), global spending on immunisation soared from US$21.4 to US$26.9 per infant in 2014. The massive economic boom in some regions of the world is expediting the growth of the paediatric vaccine market.

Key Trends Influencing the Paediatric Vaccines Market:

By indication, the pneumococcal segment accounted for a higher revenue share in global paediatric vaccines as compared to other product segments. The pneumococcal segment is expected to reach a value of US$ 31.58 Bn by 2026, reflecting a CAGR of 14.4% over the forecast period. The growth of the pneumococcal segment is attributed to the increasing incidence of infectious diseases.

In terms of revenue, the Hib vaccine segment is the second most growing segment and is expected to reach a value of US$ 13.49 Bn by 2026, growing at a CAGR of 13.4%. The hepatitis B and meningococcal segments are expected to show double-digit CAGR growth in the forecast period contributing to the growth of the global paediatric vaccine market.

By technology, the conjugate segment accounted for the highest revenue share in the global paediatric vaccine market as compared to the live or attenuated segment. The conjugate segment is expected to reach a value of US$ 32.09 Bn by 2026, reflecting a CAGR of 14.8% over the forecast period. This is expected to be closely followed by the growth of pneumococcal and meningococcal vaccines in this segment
By end user, institutional health centres account for higher demand for the paediatric vaccine as compared to other end-user segments such as hospital pharmacies and retail pharmacies. The strong growth in institutional health centres can be attributed to increasing government interventions in immunisation programs to improve vaccine coverage. Institutional health centres are expected to register the highest CAGR of 13.8% over the forecast period.

Regional analysis

By region, North America is dominating the global paediatric vaccine market due to improved healthcare infrastructure in this region. The North American paediatric vaccine market is expected to be valued at US$ 20.15 Bn by 2026 growing at a CAGR of 11.0%. In addition to North America, demand for paediatric vaccines has been significantly growing in Western Europe and APEJ. APEJ is expected to grow at a CAGR of 14.9% over the forecast period and is expected to dominate the market by 2026 by generating revenue of US$ 22.69 Bn and revenues in Western Europe are anticipated to grow by 11.2%. Middle East and Africa are expected to grow at a CAGR of 12.6% and this growth is anticipated by growth government intervention for immunisation by carrying out national-level immunisation campaigns and also disease-specific immunisation campaigns.

Key players in the global paediatric vaccine market include

Indian Immunologicals,
GlaaxoSmithKline Plc.,
Pfizer Inc.,
Sanofi, Merck & Co. Inc.,
Panacea Biotec,
Zydus Cadila,
Emergent BioSolutions Inc.,
Serum Institute of India Pvt. Ltd.,
Bharat Biotech.

Key players in the field, for instance, attribute the growth of the paediatric vaccine market to the development in the research in February 2016, GSK submitted a US regulatory submission for expanding the indication of FLuLaval Quadrivalent, an influenza vaccine, for infants more than 6 months. These developments will boost the growth of the global paediatric vaccine market.

A Full Report – Overview

Market Segmentation

Technology

Live or Attenuated Vaccine
Inactivated or Killed Vaccine
Toxoid Vaccine
Conjugate Vaccine
Subunit Vaccine
Recombinant Vector Vaccine

Indication

Pneumococcal Conjugate Vaccine
DTP Vaccine
Influenza
Meningococcal Vaccine
Polio Vaccine
Rotavirus Vaccine
MMR Vaccine
Varicella Virus Vaccine

End User

Hospital Pharmacies
Retail Pharmacies
Institutional Health Centres

Vaccine Type

Monovalent Vaccines
Multivalent Vaccines

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

North America Outbound Medical Tourism Services Industry Growth at 25% CAGR, Reaching USD 605 Billion by 2032

North America Outbound Medical Tourism Services Market

The North America Outbound Medical Tourism Services Industry is poised for a remarkable surge, according to a new report by Future Market Insights (FMI). The market, currently valued at over USD 65 billion in 2022, is projected to reach a staggering USD 605.36 billion by 2032. This translates to a phenomenal Compound Annual Growth Rate (CAGR) of 25%, signifying a significant shift in healthcare consumer behavior.

Future Market Insights, titled, derives this forecast from a recent report ‘Outbound Medical Tourism Services Market: North America Industry Analysis and Opportunity Assessment, 2016-2026.’ The report indicates that the North American outbound medical tourism services market is expected to attain a market valuation of US$ 15.53 billion by the end of 2016, with a significant increase to US$ 150.36 billion by 2026.

Future Market Insights identifies several key factors driving this substantial growth, including the presence of a sizable aging baby boomer population, a significant uninsured population, advancements in medical technology, and a wider range of treatment options. These factors are expected to fuel revenue growth in the North American outbound medical tourism services market over the forecast period.

Economic factors such as the rising rate of health insurance premiums, the high cost of medical treatments in the U.S., and parallel tourism with medical treatment are expected to boost the growth of the North American outbound medical tourism services market between 2016 and 2026. The other factors impacting the North American outbound medical tourism services markets are long waiting times for specialist appointments in the U.S. and increasing preference for non-conventional treatment options.

The demand for cosmetic correction procedures and dental treatments has been significantly high in the U.S. market in recent years, making North America the most lucrative regional market for outbound medical tourism services. According to the International Society of Aesthetic Plastic Surgery, the U.S. was the largest market for cosmetic procedures in 2015.

Lack of effective follow-up care on returning home, rampant medical malpractices in medical tourism destinations, proliferation of superbugs in medical tourism destinations, problems associated with language barriers, and privacy concerns are some of the challenges anticipated to restrict revenue growth of the North American outbound medical tourism services markets over the forecast period.

Segmentation highlights

The North American outbound medical tourism services market is segmented into the following therapeutic applications – Cosmetic Surgery Treatment, Dental Treatment, Cardiovascular Treatment, Orthopaedic Treatment, Cancer Treatment, Fertility Treatment, Weight Loss Treatment, Spinal Surgery Treatment, Neurology Treatment, and Other General Treatment.

The Cosmetic Surgery Treatment segment is estimated to be valued at US$ 3,760.9 Mn by 2016 end The Cancer Treatment segment is anticipated to register a CAGR of 22.0% over the forecast period The Orthopaedic Treatment segment is estimated to create an absolute $ opportunity of US$ 1,658.9 Mn in 2017 over 2016

Regional forecast:

The North American outbound medical tourism services market is segmented into the two top countries of the U.S. and Canada. The U.S. is projected to occupy a major share in the North American outbound medical tourism services markets in terms of value.

The U.S. market is anticipated to be valued at US$ 14.98 Bn by the end of 2016. In terms of value, the U.S. is expected to be the dominant regional market by 2026 end and is expected to register a CAGR of 25.7% over the forecast period.

Canada is expected to have comparatively less market potential for outbound medical tourism services, registering a CAGR of 18.1% over the forecast period.

Vendor insights:

The report profiles some of the top companies operating in the North American outbound medical tourism services market.

Leading market players featured in the report are Apollo Hospital Enterprise Limited, Bumrungrad International Hospital, KPJ Healthcare Berhad, Christus Muguerza Hospital, WorldMed Assist, Mednamaste, and Global Medical Tourism Inc.

Major market players are adopting strategies such as market expansion and strategic alliances to maintain their market share.

Some of these companies are also adopting strategies such as backward integration to support their core business of medical tourism.

Companies are offering services such as insurance and financing for medical tourism and are looking to expand their global footprint by enhancing their foreign customer base.

North America Outbound Medical Tourism Services Industry Segmentation

By Therapeutic Application:

Cosmetic Surgery Treatment
Dental Treatment
Cardiovascular Treatment
Orthopaedic Treatment
Cancer Treatment
Fertility Treatment
Weight Loss Treatment
Spinal Surgery Treatment
Neurology Treatment
Other General Treatment

By Region:

U.S
Canada

About Future Market Insights (FMI)

Contact Us:

North American Vision Care Market Set to Reach USD 114,800.8 Million by 2033, Growing at 5.8% CAGR

The demand for vision care products and services in North America is projected to experience robust growth, with a compound annual growth rate (CAGR) of 5.8% through 2033. This growth trajectory indicates a significant expansion from a valuation of USD 65,326.3 million in 2023 to an estimated USD 114,800.8 million by 2033.

Several factors are driving this upward trend in the vision care market, including the increasing prevalence of vision-related disorders, heightened awareness of eye health, and the growing aging population that requires more extensive eye care services. Additionally, advancements in vision correction technologies and the expanding range of vision care products available are contributing to market growth.

This notable growth trajectory reflects increasing consumer awareness about eye health, advancements in vision care technology, and a rising prevalence of vision-related issues. As the population ages and the need for effective eye care solutions intensifies, the demand for comprehensive vision care products and services is set to surge.

One of the key challenges in the industry is the high costs associated with advanced vision care treatments and procedures, limiting accessibility for a significant portion of the population. Additionally, the need for more awareness regarding the importance of regular eye check-ups and preventive measures among specific demographics has contributed to the underutilization of vision care services.

The growing adoption of teleophthalmology services and the integration of digital technologies offer avenues for expanding the reach of vision care services to remote and underserved areas. The rising consumer preference for customized vision care solutions and the increasing focus on value-based care models provide opportunities for market players to innovate and diversify their product offerings.

The integration of artificial intelligence and machine learning in vision diagnostics and treatment planning has revolutionized the sector, enabling more accurate diagnoses and personalized treatment regimens. The rising adoption of wearable vision care devices and the development of advanced nanotechnology-based treatment options are also emerging as prominent trends, shaping the future of the vision care industry in North America.

“The increasing focus on eco-friendly and sustainable vision care products has gained traction, with manufacturers emphasizing the use of biodegradable materials and eco-conscious production processes,” opines Sabyasachi Ghosh, Associate Vice President at Future Market Insights (FMI).

Key Takeaways from the North America Vision Care Market:

In 2023, Rx-Lenses dominate the market with a share of 47.1% in the North American vision care industry.
Retail Stores establish themselves as the foremost distribution channel in the North American vision care market, securing a significant market share of 61.2% in 2023.
Demand for vision care products in Canada exhibits a robust CAGR of 8.2%, expected to persist through 2033.
The United States showcases a vigorous demand for vision care products, with an impressive CAGR of 9.9% projected to endure until 2033.

Competition Outlook of North America Vision Care Market:

Key players operating in the vision care industry in North America compete through product diversification, technological advancements, and strategic collaborations to gain a competitive edge and expand their market share. Companies are focusing on enhancing their distribution networks and strengthening their brand presence to stay ahead in the industry.

Many leading players are investing heavily in research and development to introduce innovative products and technologies, catering to consumers’ diverse and evolving needs in the vision care sector. Strategic partnerships and mergers with local and international players enable companies to expand their geographic reach and offer comprehensive solutions to a broader customer base.

New entrants can capitalize on the growing demand for personalized and technologically advanced vision care solutions by introducing innovative products and services tailored to specific consumer segments. Investing in advanced manufacturing capabilities and distribution networks can help new players establish goodwill in the North America vision care industry.

North America Vision Care Market Recent Developments:

Alcon (Novartis) launches new PrecisionID technology for LASIK surgery. Alcon, a division of Novartis, has launched a new technology called PrecisionID for LASIK surgery. The new technology uses a laser to create a personalized 3D map of the patient’s eye, which is then used to guide the laser during surgery.
CooperVision launches new MiSight contact lenses for myopia control. CooperVision has launched a new line of contact lenses called MiSight. The new contact lenses are designed to slow the progression of myopia, or nearsightedness, in children.
Bausch & Lomb launches new ULTRA ONE DAY contact lenses. Bausch & Lomb has launched a new line of daily disposable contact lenses called ULTRA ONE DAY. The new contact lenses are designed to provide all-day comfort and moisture, and they also feature a UV filter to protect the eyes from the sun.
Warby Parker launches new Try-On program. Warby Parker, a direct-to-consumer eyewear company, has launched a new Try-On program. The new program allows customers to try on five pairs of glasses for five days at home before they buy.

Key Companies Providing North American Vision Care Market:

EssilorLuxottica
Johnson & Johnson Vision
Alcon (Novartis)
CooperVision
Bausch & Lomb
Warby Parker
LensCrafters
Visionworks
Pearle Vision
EyeBuyDirect
National Vision

A Full Report – Overview

North America Vision Care Market Key Segments:

By Product Type:

Rx-Lenses
Frames
Contact Lenses
Non-Rx Sunglasses
Reading Glasses
Contact Lens Solutions

By Distribution Channel:

Retail Stores
E-Commerce
Clinics

Author

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Contact Us:

Content CreationContent Creation Market Size, Share, Trends, Application Analysis and Growth from 2023 to 2033

The content creation market is projected to experience significant growth over the next decade. According to forecasts, the industry is expected to achieve a CAGR of 12.4% between 2023 and 2033. In 2023, the market is anticipated to be worth approximately US$ 166.11 billion, and it is projected to reach a value of approximately US$ 5,36,23.3 million by 2033. This reflects a substantial expansion in the industry’s size and economic impact.

The content creation market refers to the industry that produces and distributes various forms of content, such as text, images, videos, and audio. This includes industries such as publishing, film, television, and digital media. The market is driven by the increasing demand for digital content and the growth of social media platforms, which have made it easier for individuals and companies to produce and distribute content. The market is also driven by the increasing use of smartphones and other mobile devices, which have made it easier for people to access and consume content on the go.

Request a Sample Copy of the Content Creation Market Report
https://www.futuremarketinsights.com/reports/sample/rep-gb-14924

What are the main market dynamics for content creation?
Information production software makes it simpler to write, publish, and distribute digital content, which is boosting demand for content creation globally.

Widespread use of social media sites like Instagram, Twitter, Facebook, and LinkedIn, among others, is creating a number of new market prospects for content development.

On the other side, the absence of open-source software poses a significant barrier to the market’s growth.

The market for content development is also expected to grow as a result of greater digitization, increased social media marketing, and expanded high-speed internet connectivity.

How is the market for content creation categorized?
The market is divided into textual, graphical, video, audio, and other categories based on the format of the material. On the basis of tool type, the market is divided into cloud-based and on-premise content production tools, with the cloud-based segment predicted to occupy 72.4% of the market share for content creation.

The cloud is becoming more accessible to both businesses and people, enabling everyone to participate in the digital economy. The cloud is now able to handle workloads in the media and entertainment industry as creators find it easier to collaborate on stories.

What is the Competition Landscape in the Content Creation Market?

On account of the widespread adoption of content creation tools across a variety of industry verticals and the presence of leading tool developers in the region, the United States is likely to account for the major share.

The market in the US is expected to grow significantly during the forecast period with a CAGR of 11.9%.

Due to the increased usage of content creation tools and services across emerging countries, China and Japan markets are predicted to be the fastest expanding region throughout the projection period.

About Future Market Insights (FMI)

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Prosthetic Heart Valve Market Projected to Reach USD 27,277.6 Million by 2033, Growing at 7.5% CAGR

The global prosthetic heart valve market is on track for significant growth, with an estimated market size of USD 13,234.9 million by the end of 2023. Projections indicate that the market will advance rapidly, reaching a valuation of USD 27,277.6 million by 2033.

The growth in the prosthetic heart valve market is largely attributed to the rising prevalence of valvular diseases, including tricuspid regurgitation, idiopathic and ischemic mitral regurgitation, and aortic stenosis. As these conditions become more common, the demand for effective treatment options, including prosthetic heart valves, is expected to increase significantly.

When considering end users, hospitals took the lead in the global prosthetic heart valve market in 2021, commanding an estimated revenue share exceeding 75%. This dominance is expected to persist throughout the forecast period

According to Future Market Insights, an increasing prevalence of valvular heart disease (VHD) is expected to augment the growth of the global prosthetic heart valve market during the forecast period. Regulatory approval for heart valves, integration of technological advancements, and an increasing number of heart valve implantation procedures are other factors expected to influence the revenue growth of the global prosthetic heart valve market in the next 10 years. However, high costs associated with transcatheter heart valve products, procedure-related risks and complications, and product recalls are some restraints likely to hamper the growth of the global prosthetic heart valve market over the forecast period.

Segmentation highlights

The global prosthetic heart valve market is segmented on the basis of Product Type (Mechanical Heart Valves, Biological/Tissue Heart Valves, Transcatheter Heart Valves) and End User (Hospitals, Ambulatory Surgery Centres).

The Transcatheter Heart Valves product type segment is estimated to be valued at US$ 6,069.1 Mn by 2026 end, registering a CAGR of 13.3% between 2016 and 2026
The Hospitals end user segment accounted for 74.5% market share of the global prosthetic heart valve market in 2015. Rising demand for quicker treatment options and remedies is expected to promote the revenue growth of the Hospitals segment over the forecast period

Regional market projections

The global prosthetic heart valve market is segmented by region into North America, Latin America Excluding Brazil, Brazil, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), and Middle East & Africa (MEA). The global prosthetic heart valve market is largely prominent in the developed regions.

The North America regional market is estimated to witness the highest CAGR of 12.4% during the forecast period followed by the Western Europe regional market at 12.1%. Factors such as legislative openness and inline approval procedures are expected to contribute largely to the revenue generation potential and attractiveness of the Western Europe prosthetic heart valve market. Rising adoption of transcatheter heart valves in geriatric patients for better care is expected to fuel revenue growth in the Japan prosthetic heart valve market over the forecast period.

Vendor insights

The report on the global prosthetic heart valve market profiles some of the leading companies dominating the global prosthetic heart valve market. Top market players featured in the global prosthetic heart valve market report are Edwards Lifesciences Corporation, St. Jude Medical, Inc., Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, SYMETIS, LivaNova PLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve LLC, and JenaValve Technology, Inc. Leading market players are focussing on delivering differentiated therapies to cardiac patients and are strengthening their foothold in the global prosthetic heart valve market through strategic collaborations and acquisitions.

Key competitors covered in terms of prosthetic heart valve market are Edwards Lifesciences Corporation, St. Jude Medical, Inc., Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, SYMETIS, LivaNovaPLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve, LLC, and JenaValve Technology, Inc.

Key strategies adopted by most of the major players in the global prosthetic heart valve market include:

product approvals and commercialisation, leveraging existing capabilities to create patient-centric technologies, briskly entering markets in emerging countries and offering the latest innovative technologies to healthcare facilities and, thus strengthening regional proficiency and addressing customer needs. New product launches, innovation and expansion are anticipated to form the core of these strategies during the forecast period.

A Full Report – Overview

Key Segment

By Product Type

Mechanical Heart Valves
Mechanical Aortic Valve
Mechanical Mitral Valve
Biological/Tissue Heart Valves
Tissue Aortic Valve
Tissue Mitral Valve
Transcatheter Heart Valves
Transcatheter Aortic Valve
Transcatheter Mitral Valve

By End User

Hospitals
Ambulatory Surgery Centres

About Future Market Insights (FMI)

Contact Us:

Form Automation Software Market In-Depth Analysis with Booming Trends Supporting Growth and Forecast 2024-2034

The form automation software market size stands at USD 364 million in 2024 and is anticipated to surpass a valuation of USD 1,780 million by 2034. The form automation software market expansion is estimated at a CAGR of 17.2% from 2024 to 2034.

Businesses across industries are increasingly adopting digital transformation strategies to streamline operations, enhance customer experiences, and stay competitive. Form automation plays a crucial role in this transformation by digitizing manual processes, reducing paper-based workflows, and integrating seamlessly with other digital systems like CRM and ERP. This trend is accelerating the demand for flexible, scalable form automation solutions that can support modern digital ecosystems.

Organizations are increasingly leveraging data analytics to gain actionable insights from form submissions and customer interactions. Form automation software that offers built-in analytics tools, reporting dashboards, and customizable metrics is in high demand. These capabilities enable businesses to track form performance, identify trends, and optimize processes for better decision-making and operational efficiency. This trend underscores the importance of data-driven insights in driving business growth and competitive advantage.

Advances in AI (Artificial Intelligence) and ML (Machine Learning) are transforming form automation by enabling intelligent data extraction, predictive analytics, and automation of complex decision-making processes. AI-powered form automation solutions can analyze unstructured data, detect patterns, and automate routine tasks such as data validation and classification. This trend is driving innovation in form automation, making processes smarter, more efficient, and less reliant on manual intervention.

Key Takeaways from the Form Automation Software Market Report

The global market size expanded at a 15.1% CAGR from 2019 to 2023.
The software platform segment holds 68.7% of shares in 2024.
The web-based deployment type segment captured 72.6% of shares in 2024.
The market size in Australia and New Zealand is anticipated to develop at an 18.4% CAGR through 2034.
The market size in the United Kingdom is estimated to surge at a 17.6% CAGR through 2034.
The market size in India is expected to increase at a 17.8% CAGR through 2034.

Competitive Landscape

The form automation software market is marked by a diverse array of players, from tech giants like Microsoft, Google, and Adobe to mid-sized firms such as Nintex, Formstack, and Zoho, as well as agile startups like JotForm, Typeform, and Cognito Forms. Established companies leverage their broad ecosystems and global reach to offer integrated, scalable solutions, while mid-sized firms focus on specialized features and industry-specific needs, ensuring agility and rapid innovation. Startups and niche players emphasize user-friendly, cost-effective solutions with quick deployment and strong customer support, appealing to small businesses and individual users.

Recent Developments

In May 2024, Jotform reported reaching 25 million global users. This is a 25% increase in year-over-year client acquisition and maintains Jotform’s growth across many business categories, including user numbers, revenue, enterprise customer adoption, and product innovation.
In September 2023, SurveyMonkey introduced SurveyMonkey Forms. Users will be able to construct online forms with pre-built templates, customizable fields, third-party connections, and process automation to increase form creation productivity.

Note from the Analysts

“In the form automation software market, success revolves around innovation in AI integration, seamless enterprise integration, and stringent data security. Key players should focus on enhancing automation capabilities, ensuring regulatory compliance, and prioritizing customer satisfaction to maintain a competitive edge.” Says a Lead Analyst at Future Market Insights (FMI).

Key Players in the Form Automation Software Industry

Microsoft
Google
Adobe
Salesforce
IBM
Oracle
Nintex
Formstack
Zoho
JotForm
Typeform
Wufoo
PandaDoc
DocuSign
Laserfiche
K2
ProntoForms
Cognito Forms
Gravity Forms
Smartsheet

Form Automation Software Market Segmentation Analysis

By Component:

The industry is segmented into services and software platforms.

By Pricing Analysis:

The sector is bifurcated into licensing based and subscription-based.

By Deployment Type:

The industry is classified into on-premises and web-based.

By Region:

Analysis of the industry has been conducted in the countries of North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East & Africa (MEA).

Request a Sample of this Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14918

About Future Market Insights (FMI)

Contact Us:

Coronary Stents Market to Reach USD 51.2 Billion by 2032, Growing at 11.8% CAGR

The fight against heart disease is gaining momentum with advancements in coronary stents. The global Coronary Stents Market is projected to reach a substantial USD 51.2 billion by 2032, reflecting a steady growth trajectory. This translates to a projected Compound Annual Growth Rate (CAGR) of 5.1% from 2022 to 2032. In 2022, the market was valued at an estimated USD 33.36 billion.

Coronary stenting offers several significant advantages, including a substantial improvement in blood flow and the prevention of further damage to the heart muscle. These procedures not only alleviate symptoms of heart disease—such as angina and shortness of breath—but also reduce the need for more invasive surgeries like coronary bypass surgery. As a result, surgeons are increasingly opting for stenting procedures, which are minimally invasive and offer quicker post-operative recovery times for patients.

The increasing awareness of the manifold benefits associated with stenting procedures, such as the significant enhancement of blood flow and protection against further damage to the heart muscle, is a pivotal driver of market expansion. Stenting also offers a means to ameliorate heart disease symptoms, including angina and shortness of breath, ultimately reducing the necessity for coronary bypass surgery. Consequently, both surgeons and patients, given its minimally invasive nature and relatively brief post-operative recovery period, favor stenting.

Furthermore, a rise in the global geriatric population is leading to a larger patient pool with serious cardiovascular diseases. Again, hypertension is arising as a grave public health concern. Obesity, too, adds to this burden as one of the primary risk factors accountable for different cardiovascular diseases worldwide.

Coronary stenting is prescribed to patients who are suffering from coronary artery blockage. Though angioplasty is the first line of treatment for patients with acute coronary artery blockages the number of patients undergoing stenting has been increasing steadily over the last ten years. This is owing to the rise of outpatient coronary stenting procedures, which shortens long hospital stays. Additionally, a large number of cardiologists prescribing stenting procedures for patients with CAD is a prime factor that will likely fuel revenue growth of the coronary stent market during the forecast period.

“Increasing cases of lifestyle diseases like obesity and diabetes often result in heart issues which, in turn, supplements the global growth of the coronary stents market over the forecast period,” says an FMI analyst.

Coronary Stents Market Key Takeaways:

Rising awareness of the benefits associated with stenting will strengthen market prospects.
Prevalence of alternative treatment methods, product failure, and recalls are certain factors that may hamper market growth.
Growing cases of coronary artery diseases propel the coronary stent market in the United States.
Favorable government support for the healthcare sector will present new market opportunities in China.

Coronary Stents Market Competitive Landscape

Abbott, Medtronic, Boston Scientific Corporation, Terumo Corporation, B Braun Melsungen AG, Biotronik, Stentys SA, MicroPort Scientific Corporation, C. R. Bard, Inc., and Cook Medica among others are some of the major players in the coronary stents market profiled in the full version of the report.

Key market players are focusing on product upgrades and offering new features to meet the rising consumer demand. These organizations are employing strategies like new product releases, partnerships, collaborations, mergers, and acquisitions to gain a competitive advantage.

More Insights into Coronary Stents Market Report

In its latest report, FMI offers an unbiased analysis of the global coronary stents market, providing historical data from 2016 to 2021 and forecast statistics for 2022 to 2032. To understand the global market potential, growth, and scope, the market is segmented based on product type (drug-eluting stent (DES), bare metal stent (BMS), bioresorbable vascular stent (BVS)), raw material (cobalt chromium, stainless steel, platinum-chromium, nickel-titanium, polymer), end user (hospitals, ambulatory surgical centers, cardiac catheterization laboratories), and region.

According to the latest FMI reports, based on region, China’s coronary stent market will likely exhibit an impressive growth rate during the observation period due to favorable government support for the healthcare sector. The coronary stent market in the United States is anticipated to demonstrate substantial growth over the forecast period. The rising prevalence of coronary artery disease is spurring the demand for interventional cardiology treatment in this country. Sedentary lifestyles, smoking, poor dietary habits, and pollution often contribute to increasing cases of cardiovascular diseases. All of these factors are expected to drive the demand for the target market during 2022-2032.

Key Segments Covered in the Coronary Stents Market Analysis

By Product:

Drug Eluting Stent (DES)
Bare Metal Stent (BMS)
Bioresorbable Vascular Stent (BVS)

By Raw Material:

Cobalt-Chromium
Stainless Steel
Platinum – Chromium
Nickel – Titanium
Polymer

By End User:

Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI is the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Stream Hosting Market In-Depth Analysis with Booming Trends Supporting Growth and Forecast 2022-2032

The global stream hosting market is expected to expand at a 14.8% CAGR, with the market valuation reaching US$ 4 Billion in 2022. As per the report, the global stream hosting market size will reach US$ 16 Billion by 2032.

The incorporation of advanced technologies in the digital media industry is anticipated to drive sales in the market. Additionally, the growing need to increase the consumer base and optimize network bandwidth for live & on-demand streaming content will augment growth.

Online video continues to grow in popularity at the expense of traditional broadcast viewing. Viewers spend an average of six hours per week watching multiple types of internet videos, up 59 percent from 2016. Television viewing fell by 10% to roughly seven hours during the same period the previous year.

Individuals also appreciate internet streaming services for their ease, variety, flexibility, and cost-effectiveness. Unlike traditional TV viewers, video-on-demand users are not limited in their content choices by geography.

Viewers have switched from traditional televisions to on-demand video streaming services due to the ability to watch videos on the go via mobile apps and high-speed network connectivity. These factors are projected to boost the growth in the stream hosting market in the forthcoming years.

Besides this, a surging preference for cloud video hosting will create opportunities for growth in the market. Cloud video hosting reduces the need for infrastructure as compared to traditional video hosting.

Organizations are looking for a more secure, reliable & scalable cloud video hosting platform as a result of the rapid growth of video hosting & streaming platforms. Cloud services are cost-effective, hence sales of cloud video services are expected to gain traction.

Key Takeaways from the Stream Hosting Market Report:

The stream hosting market is poised for significant growth, with video streaming sales projected to surge at a remarkable 16.2% CAGR in the coming years. Smartphones and tablets are anticipated to dominate the platform landscape by 2032, while the media and entertainment sector will continue to be the most profitable industry segment. Notably, the U.S. is set to maintain its stronghold in the North American market, capturing an impressive 82% share in 2022. Additionally, the U.K. market is expected to experience substantial growth, with sales forecasted to increase by 4.7 times during the assessment period. Mexico also emerges as a promising market, with sales expected to soar at an impressive 18.7% CAGR through 2032, signaling opportunities for robust expansion and investment.

Leading Key Players:

Major key players in the stream hosting market include Dacast Inc., Brightcove Inc., Wistia, JW Player, Kaltura Inc., Vimeo Inc., DigitalOcean LLC, IBM Watson Media, Vidyard, Facebook (Meta Inc.), YouTube (Google), SproutVideo, Cincopa, Muvi LLC, Twitch (Amazon), Hippo Video, StreamShark, Wowza Media Systems LLC, and Primcast.

Regional Outlook:

The adoption of stream hosting services varies across regions, influenced by factors such as internet penetration, digital infrastructure, regulatory frameworks, and cultural preferences. North America, with its mature streaming market and robust technological ecosystem, remains a key revenue contributor to the global stream hosting industry. The presence of major streaming platforms, content creators, and technology providers further consolidates the region’s dominance.

Request a Sample of this Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14914

About Future Market Insights (FMI)

Contact Us:

Network Sandboxing Market Soars to US$ 34.9 Billion with 15.7% CAGR by 2032

Many enterprises are trying to adopt the BYOD policy for the betterment of their employees and the corresponding work assigned to the employees. BYOD provides several benefits to the users such as cost reduction, and a flexible working environment.
Data security is one of the most important and biggest concerns when it comes to the adoption of BYOD policy in business processes. As a result of this, the BYOD policy implemented in the enterprises is driving the demand for network sandboxing solutions.

As per cybersecurity vendor McAfee, cloud-based data is more vulnerable than data on on-site servers. Therefore, the cloud computing platform is one of the targeted cyber environments. According to Triskele Labs, cloud cyber-attacks account for 20% of all cyber-attacks.
In recent years, the popularity of cloud computing has evolved substantially. Off-site service platforms offer computing, storage, or hosting services with the help of cloud infrastructure. Such cloud infrastructure is highly vulnerable to cyber-attacks.

For instance, in 2020 an adult live-streaming website CAM4 fell victim to a cloud cyber-attack and exposed around 10.8 Billion sensitive entries (up to 7 TB of data). Therefore, a growing number of cloud cyber-attacks ultimately are fueling the demand for network sandboxing market.

Key Takeaways from the Network Sandboxing Market Report:

By component, the solution segment is anticipated to account for the leading share in the global demand for network sandboxing during the forecast period. However, the services segment is estimated to grow at a higher CAGR of 16.7% through 2032.
Among the enterprise size, the SME segment is estimated to grow at a higher CAGR of 17.4% during the forecast period.
By vertical, the BFSI segment is anticipated to grow at a leading CAGR of 19.1% between 2022 & 2032.
North America is dominating the network sandboxing market followed by Europe in 2022. South Asia & Pacific is estimated as the fastest growing region during the forecast period.
The U.S. network sandboxing market is expected to progress at a CAGR of around 11.5% through 2032.
In the East Asia region, the China network sandboxing market is expected to grow by 5.6X during the forecast period. Moreover, Japan is expected to grow at the highest CAGR of 20.9% during the forecasted period.

Leading Key Players:

Check Point Software Technologies
Cisco Systems
Fortinet
FireEye
Microsoft
Juniper Networks
Palo Alto Networks
Sophos
Symantec Corporation (Broadcom)
Forcepoint
McAfee
SonicWall
Zscaler
Crowdstrike
Lastline
ContentKeeper Web Filter Pro

Network Sandboxing Market Segmentation:

By Component:

Solution
- Standalone Network Sandbox
  - Hardware
  - Cloud-based
- Integrated Network Sandbox
  - Hardware
  - Cloud-based
Service
- Professional Services
  - Consulting
  - Training and Education
  - Support & Maintenance
- Managed Services

By Enterprise Size:

Small and Mid-Sized Enterprises (SMEs)
Large Enterprises

By Vertical:

BFSI
Government and defense
Retail
Healthcare
IT and telecom
Education
Others

By Region:

North America
Latin America
Europe
East Asia
South Asia & Pacific
Middle East and Africa (MEA)

Get Instant Access to Your Visuals-Packed Report, request a sample at
https://www.futuremarketinsights.com/reports/sample/rep-gb-14862

About Future Market Insights (FMI)

Contact Us: